Effects of Teriparatide Compared with Risedronate on Recovery After Pertrochanteric Hip Fracture: Results of a Randomized, Active-Controlled,Double-Blind Clinical Trial at 26 Weeks

J Bone Joint Surg Am. 2016 Nov 16;98(22):1868-1878.

Osteoporosis drugs might affect fracture-healing. We therefore studied the effects of teriparatide in comparison with risedronate on recovery after pertrochanteric hip fractures. Teriparatide was associated with less pain and a shorter time to complete the TUG test between 6 and 26 weeks compared with risedronate. Other fracture-recovery outcomes were similar. The results should be interpreted with caution as these were secondary end points.

Autor: Aspenberg P, Malouf J, Tarantino U, García-Hernández P, Corradini C, Overgaard S, Stepan JJ, Borris , Lespessailles E,Frihagen F, Papavasiliou K, Petto H, Caeiro JR, Marin F
Patrocinadores de la web
Laboratorios Rubió
Grupo Italfármaco
Gedeon Richter
Kyowa Kirin